Latest news from Acta Pharmaceutica Sinica B on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/development-and-clinical-advancement-of-small-molecules-for-ex-vivo-expansion-of-hematopoietic-nbsp-stem-cell/?sc=rsin /articles/development-and-clinical-advancement-of-small-molecules-for-ex-vivo-expansion-of-hematopoietic-nbsp-stem-cell/?sc=rsin Tue, 21 Dec 2021 02:00:24 EST Hematopoietic stem cell (HSC) transplantation is the only curative therapy for many diseases. HSCs from umbilical cord blood (UCB) source have many advantages over from bone marrow. However, limited HSC dose in a single CB unit restrict its ... Acta Pharmaceutica Sinica B